BioPower Operations Corporation Selling, General and Administrative Expense
BioPower Operations Corporation reported Selling, General and Administrative Expense of $4.45 million for the 3-month period ending 2023-05-31, per its 10-Q filed 2023-08-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-08-22
- BioPower Operations Corporation selling, general and administrative expense for the quarter ending 2023-05-31 was $4.45M, a 1993.01% increase year-over-year.
- BioPower Operations Corporation selling, general and administrative expense for the quarter ending 2023-02-28 was $50.85K, a 66.42% decline year-over-year.
- BioPower Operations Corporation selling, general and administrative expense for the quarter ending 2022-11-30 was $396.16K, a 57.34% increase year-over-year.
- BioPower Operations Corporation selling, general and administrative expense for the quarter ending 2022-08-31 was $403.45K, a 100.33% increase year-over-year.
- BioPower Operations Corporation selling, general and administrative expense for fiscal 2022 was $1.16M, a 152.24% increase from fiscal 2021.
- BioPower Operations Corporation selling, general and administrative expense for fiscal 2021 was $461.26K.
- BioPower Operations Corporation selling, general and administrative expense for fiscal 2013 was $1.30M, a 32.16% increase from fiscal 2012.
- BioPower Operations Corporation selling, general and administrative expense for fiscal 2012 was $984.87K, a 2.10% increase from fiscal 2011.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 27 month | Selling, General and Administrative Expense 39 month |
|---|---|---|---|---|---|---|
| 2023-05-31 | $4.45M 10-Q · filed 2023-08-22 | $4.50M 10-Q · filed 2023-08-22 | $4.89M derived: sum of 3 quarters · filed 2023-08-22 | $5.30M derived: sum of 4 quarters · filed 2023-08-22 | ||
| 2023-02-28 | $50.85K 10-Q/A · filed 2023-08-22 | $447.01K derived: sum of 2 quarters · filed 2023-08-22 | $850.47K derived: sum of 3 quarters · filed 2023-08-22 | $1.06M derived: sum of 4 quarters · filed 2023-08-22 | ||
| 2022-11-30 | $396.16K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-06-16 | $799.62K derived: sum of 2 quarters · filed 2023-06-16 | $1.01M derived: sum of 3 quarters · filed 2023-08-22 | $1.16M 10-K · filed 2023-06-16 | ||
| 2022-08-31 | $403.45K 10-Q/A · filed 2022-12-14 | $615.89K derived: sum of 2 quarters · filed 2023-08-22 | $767.32K 10-Q/A · filed 2022-12-14 | $1.02M derived: sum of 4 quarters · filed 2023-08-22 | ||
| 2022-05-31 | $212.44K 10-Q · filed 2023-08-22 | $363.87K 10-Q · filed 2023-08-22 | $615.65K derived: sum of 3 quarters · filed 2023-08-22 | $817.05K derived: sum of 4 quarters · filed 2023-08-22 | ||
| 2022-02-28 | $151.43K 10-Q/A · filed 2023-08-22 | $403.21K derived: sum of 2 quarters · filed 2023-08-22 | $604.61K derived: sum of 3 quarters · filed 2023-08-22 | $612.69K derived: sum of 4 quarters · filed 2023-08-22 | ||
| 2021-11-30 | $251.79K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-06-16 | $453.18K derived: sum of 2 quarters · filed 2023-06-16 | $461.26K derived: sum of 3 quarters · filed 2023-06-16 | $461.26K 10-K · filed 2023-06-16 | ||
| 2021-08-31 | $201.40K 10-Q/A · filed 2022-12-14 | $209.48K derived: sum of 2 quarters · filed 2022-12-14 | $209.48K 10-Q/A · filed 2022-12-14 | |||
| 2021-05-31 | $8.08K 10-Q · filed 2022-07-15 | $8.08K 10-Q · filed 2022-07-15 | ||||
| 2013-11-30 | $1.30M 10-K · filed 2014-03-17 | $3.25M 10-K · filed 2014-03-17 | ||||
| 2012-11-30 | $984.87K 10-K · filed 2014-03-17 | $1.95M 10-K/A · filed 2013-08-20 | ||||
| 2011-11-30 | $964.60K 10-K/A · filed 2013-08-20 |